ZOETIS INC CLASS A (ZTS)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ZTS
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ZTS | Executive Vice President, Global Corporate Affairs, at Johnson & Johnson | 57 | ["Critical public policy and government affairs expertise","Executive leadership role at Johnson & Johnson","Insights on communications, brand reputation management, marketing and regulatory matters","Extensive commercial experience from senior leadership roles across multiple pharmaceutical companies","Responsibility for global commercial strategy, M&A activity, pipeline development and new product launches","Extensive government relations network","Proven ability to navigate complex product challenges and political environments","Governance acumen from serving on a Fortune 500 executive team"] | ["Corporate Governance","Quality and Innovation","Corporate Governance Committee","Quality and Innovation Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Independent Director Executive Vice President, Global Corporate Affairs, at Johnson & Johnson Director since: July 2022 Committees: Corporate Governance; Quality and Innovation Age: 57 Other Current Public Company Directorships: None Currently serves as Executive Vice President, Global Corporate Affairs at Johnson & Johnson, leading corporate marketing, government relations, global communications, public health and philanthropy functions, with previous responsibility as Company Group Chairman for Global Commercial Strategy for Pharmaceuticals, bringing deep expertise in public policy, brand reputation management and strategic communications. Additionally, she possesses expertise in corporate communications strategy, human capital management and an extensive network for advisor recommendations and strategic partnerships. Extensive commercial and operational experience across the pharmaceutical industry, having served as President of Cardiovascular and Metabolism at Johnson & Johnson and General Manager of multiple business units at Amgen, with proven track record in pipeline development, new product launch strategy and leading M&A activity. Provides valuable strategic counsel on navigating regulatory and political environments, drawing from experience managing complex product challenges, and serves as a trusted advisor to management on Washington D.C. policy matters, tariff exemptions and pharmaceutical industry positioning with both human and animal health applications. Career Highlights: Johnson & Johnson (NYSE: JNJ) a global pharmaceutical and healthcare company Executive Vice President, Global Corporate Affairs (2021-present) Company Group Chairman, Global Commercial Strategy for Pharmaceuticals (2019- 2021) President, Cardiovascular and Metabolism (2017-2018) Various senior leadership roles (2017) Amgen Inc. (NASDAQ: AMGN) a global biotechnology company General Manager, Cardiovascular and Bone Business Units (2014-2017) General Manager, Inflammation and Cardiovascular Business Units (2013-2014) Novartis AG (NYSE: NVS) a global pharmaceutical company Head, Global Gastroenterology Marketing (2003-2005) Abbott Laboratories (NYSE: ABT) a global healthcare company Various roles of increasing responsibility (1994-2003) Education: Bachelor of Arts degree from the University of Colorado Master of Business Administration from the Ross School of Business at the University of Michigan (Consortium Fellow)